Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.23M Buy
23,034
+512
+2% +$179K 0.04% 425
2025
Q4
$7.61M Buy
22,522
+1,176
+6% +$401K 0.04% 375
2025
Q3
$6.65M Buy
21,346
+1,991
+10% +$586K 0.04% 354
2025
Q2
$5.81M Buy
19,355
+5,705
+42% +$1.64M 0.04% 331
2025
Q1
$3.68M Buy
13,650
+1,472
+12% +$370K 0.04% 363
2024
Q4
$2.79M Buy
12,178
+1,753
+17% +$412K 0.03% 397
2024
Q3
$2.34M Buy
10,425
+4,555
+78% +$1.06M 0.05% 339
2024
Q2
$1.32M Buy
5,870
+3,489
+147% +$808K 0.06% 281
2024
Q1
$579K Buy
+2,381
New +$547K 0.08% 241

Other funds holding COR

&Partners's COR Position: Q1 2026 in Review

&Partners increased its Cencora (COR) stake by 2.3% in Q1 2026, buying an estimated $179K and bringing the position to 23,034 shares worth $7.23M. The position accounts for 0.04% of the portfolio, ranked #425.

&Partners first reported a position in COR in Q1 2024 and has held it in 9 quarters since. The position peaked at $7.61M in Q4 2025. 1,426 funds tracked by Wall St. Rank hold COR as of Q1 2026.

  • &Partners held 23,034 shares of Cencora worth $7.23M as of Q1 2026.
  • &Partners bought 512 Cencora shares in Q1 2026, an estimated $179K.
  • Cencora made up 0.04% of &Partners's portfolio in Q1 2026, its #425 holding.
  • &Partners first reported a position in Cencora in Q1 2024 and has held it in 9 quarters since.
  • &Partners's Cencora position peaked at $7.61M in Q4 2025.
  • 1,426 funds tracked by Wall St. Rank held Cencora as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.